Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies: Draft Guidance for Industry
Information
Type
Guidance
Regulated products
Biologics, Drugs, Medical Devices
Topics
Pediatric Product Development
Published
June 26, 2024
Last updated
July 3, 2024
Description
Draft guidance for industry on implementing diversity action plans to enhance enrollment of underrepresented populations in clinical studies.
Tags
Organization
Country / Region
United States
License
Other (Public Domain)